Global Geographic Tongue Causes Market Research Report, Diagnosis (Biopsy, Tests), Treatment (Topical Corticosteroids, Zinc Supplements, Topical Anaesthetic), End User (Hospitals & Clinics, Research Organization, Diagnostic Labs) - Global Forecast Till 2023
The Global Geographic Tongue Causes shows market is expected to grow at an approximate CAGR of 10.6% during the forecast period.
Geographic tongue is characterized by the tongue inflammation and is marked by the absence of papillae, which are small bumps present under normal conditions. General discomfort of the tongue or mouth, soreness or a burning sensation of the tongue are some of the common symptoms for the disease. Increasing prevalence of the psoriasis and growing geriatric population are some of the major drivers for the market growth. Additionally, growing oral healthcare expenditures are estimated to fuel the market growth during the forecast period. However, lack of awareness, limited availability of the treatment procedures and low per capita healthcare expenditure in the middle and low income countries are some of the restraining factor for the market growth.
Geographic tongue is characterized by the tongue inflammation and is marked by the absence of papillae, which are small bumps present under normal conditions. General discomfort of the tongue or mouth, soreness or a burning sensation of the tongue are some of the common symptoms for the disease. Increasing prevalence of the psoriasis and growing geriatric population are some of the major drivers for the market growth. Additionally, growing oral healthcare expenditures are estimated to fuel the market growth during the forecast period. However, lack of awareness, limited availability of the treatment procedures and low per capita healthcare expenditure in the middle and low income countries are some of the restraining factor for the market growth.
Geographic Tongue Market Key Players
Quest Diagnostics (U.S.), Sonic Healthcare (Australia), Merck KGaA (Germany), Jost Chemical Co. (U.S.), Pfizer Inc. (U.S.), AstraZeneca (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Danaher (U.S.) and others are some of the key players in the global geographic tongue market.
Geographic Tongue Market Segmentation
The Global Geographic Tongue Market is segmented on the basis of diagnosis, treatment, and end user.
On the basis of the diagnosis, the market is segmented into physical examinations, biopsy, tests, and others. The tests segment is sub-segmented into vitamin B testing, HLA B antigen testing, and others.
On the basis of the treatment, the market is segmented into topical corticosteroids, zinc supplements, topical anesthetic, and others.
On the basis of the end user, the market is segmented into hospitals & clinics, research organization, diagnostic labs, and others
Geographic Tongue Market Regional Analysis
America dominates the global geographic tongue market. Factors such as the presence of a developed healthcare sector, rising patient population for diseases like psoriasis, increasing per capita healthcare expenditure are the major drivers for the market growth within the region. Moreover, the presence of the key players within the region boosts the market growth during the forecast period.
Europe holds the second largest market for geographic tongue owing to the rising research and developments in healthcare sector, increasing government funding and presence of huge patient population.
Asia Pacific region is the fastest growing market. Rising healthcare expenditures, developing pharmaceutical & biotechnological sector and growing geriatric population are the major drivers for the market growth within the region.
On the other hand, the Middle East & Africa hold the least share in the global geographic tongue market. Absence of the developed healthcare services, especially in the African Region restrains the market growth within the region.
Geographic Tongue Market Segmentation
The Global Geographic Tongue Market is segmented on the basis of diagnosis, treatment, and end user.
On the basis of the diagnosis, the market is segmented into physical examinations, biopsy, tests, and others. The tests segment is sub-segmented into vitamin B testing, HLA B antigen testing, and others.
On the basis of the treatment, the market is segmented into topical corticosteroids, zinc supplements, topical anesthetic, and others.
On the basis of the end user, the market is segmented into hospitals & clinics, research organization, diagnostic labs, and others
